Walid M. Awni - Concepedia

Author

Walid M. Awni

Hennepin County Medical Center

Also Known As

W AWNI, W Awni, W M Awni, W. Awni, W. M. Awni, W.M Awni, W.M. Awni, WALID M. AWNI, Wald M. Awni, Walid Awni

160

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

Hennepin County Medical Center AbbVie (United States)Abbott Fund Abbott (United Kingdom)Abbott (United States)

About

Walid M. Awni is an author at Hennepin County Medical Center specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	46	1.9K
2	Health Sciences	2	2	35
3	Natural Sciences	1	1	20
4	Social Sciences	1	1	23
5	Allergy	1	1	77

Walid M. Awni

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
First-pass metabolism of cyclosporin by the gut Joseph C. Kolars, Paul B. Watkins, Robert M. Merion, The Lancet First-pass MetabolismMedicinePhysiologyGastroenterologyDigestive Tract	1991	428
The Tablet Formulation of Lopinavir/Ritonavir Provides Similar Bioavailability to the Soft-Gelatin Capsule Formulation With Less Pharmacokinetic Variability and Diminished Food Effect Cheri E. Klein, Yi‐Lin Chiu, Walid M. Awni, JAIDS Journal of Acquired Immune Deficiency Syndromes Diminished Food EffectPharmaceutical ScienceRitonavir ExposuresActive IngredientMedicine	2007	151
Drug-drug interaction profile of the all-oral anti-hepatitis C virus regimen of paritaprevir/ritonavir, ombitasvir, and dasabuvir Rajeev Menon, Prajakta Badri, Tianli Wang, Journal of Hepatology	2015	125
The Adverse Impact of Cyclosporine on Serum Lipids in Renal Transplant Recipients Bertram L. Kasiske, Kathryn Tortorice, K L Heim-Duthoy, American Journal of Kidney Diseases Adverse ImpactKidney TransplantKidney TransplantationImmunosuppressive TherapyPharmacology	1991	124
THE RELATIONSHIP BETWEEN CYCLOSPORINE PHARMACOKINETIC PARAMETERS AND SUBSEQUENT ACUTE REJECTION IN RENAL TRANSPLANT RECIPIENTS Bertram L. Kasiske, K L Heim-Duthoy, K. Venkateswara Rao, Transplantation Transplant RejectionUrologyTransplantationKidney TransplantCsa Kinetic Parameters	1988	112
Pharmacokinetics and Exposure–Efficacy Relationship of Adalimumab in Pediatric Patients with Moderate to Severe Crohnʼs Disease Shringi Sharma, Doerthe Eckert, Jeffrey S. Hyams, Inflammatory Bowel Diseases	2015	97
Are Bioequivalence Studies of Levothyroxine Sodium Formulations in Euthyroid Volunteers Reliable? Vicky A. Blakesley, Walid M. Awni, Charles Locke, Thyroid	2004	86
Pharmacokinetics and Dose Recommendations for Cyclosporine and Tacrolimus When Coadministered With ABT-450, Ombitasvir, and Dasabuvir Prajakta Badri, Sheetij Dutta, Eoin Coakley, American Journal of Transplantation	2015	82
Effect of chronic 5-lipoxygenase inhibition on airway hyperresponsiveness in asthmatic subjects. Andrew R. Fischer, Caroline McFadden, Robert P. Frantz, American Journal of Respiratory and Critical Care Medicine AsthmaInflammatory Lung DiseaseLung InflammationChronic 5-Lipoxygenase InhibitionWhole Blood	1995	77
Pharmacokinetics and pharmacodynamics of codeine in end-stage renal disease David R.P. Guay, Walid M. Awni, John W. A. Findlay, Clinical Pharmacology & Therapeutics	1988	74

Page 1